PLAU and cancer: Urokinase plasminogen activator uPA and its receptor uPAR are overexpressed in several malignant tumors (Montuori & Ragno, 2014) and could also be served as prognostic markers in cancer (Roy & Walsh, 2014; McMahon & Kwaan, 2015).